| Date Filed | Type | Description |
| 05/25/2023 |
4
| Claiborne Cary J (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Granted 420,000 shares
@ $0
Granted 300,000 options to buy
@ $0.3025, valued at
$90.8k
|
|
| 09/20/2022 |
4
| Claiborne Cary J (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 shares
@ $0.4294, valued at
$10.7k
Granted 75,000 shares
@ $0.4202, valued at
$31.5k
|
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
3
| Claiborne Cary J (Director) has filed a Form 3 on ADIAL PHARMACEUTICALS, INC. |
| 12/17/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/15/2014 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 22,027 options to buy
@ $6.75, valued at
$148.7k
Granted 25,000 options to buy
@ $6.75, valued at
$168.8k
|
|
| 07/10/2014 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 267 shares
@ $6.56, valued at
$1.8k
|
|
| 07/10/2014 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 220 shares
@ $6.79, valued at
$1.5k
|
|
| 02/28/2014 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Sold 2,390 shares
@ $9, valued at
$21.5k
Sold 110 shares
@ $9.06, valued at
$996.6
Exercised 2,500 options to buy
@ $4.07, valued at
$10.2k
|
|
| 01/09/2014 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Sold 2,500 shares
@ $9, valued at
$22.5k
Exercised 2,400 options to buy
@ $4.41, valued at
$10.6k
Exercised 100 options to buy
@ $4.07, valued at
$407 |
|
| 01/06/2014 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 196 shares
@ $8.93, valued at
$1.8k
|
|
| 11/26/2013 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Exercised (in-or-at-the-money) 3,511 shares
@ $7.46, valued at
$26.2k
Exercised (in-or-at-the-money) 12,989 shares
@ $7.64, valued at
$99.2k
Exercised (in-or-at-the-money) 3,511 options to buy
@ $4.07, valued at
$14.3k
Exercised (in-or-at-the-money) 12,940 options to buy
@ $4.07, valued at
$52.7k
Exercised (in-or-at-the-money) 49 options to buy
@ $4.07, valued at
$199.4 |
|
| 10/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/29/2013 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Exercised (in-or-at-the-money) 10,300 shares
@ $9.0034, valued at
$92.7k
Exercised (in-or-at-the-money) 8,300 options to buy
@ $4.07, valued at
$33.8k
Exercised (in-or-at-the-money) 2,000 options to buy
@ $4.41, valued at
$8.8k
|
|
| 01/04/2013 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 376 shares
@ $4.655, valued at
$1.8k
|
|
| 10/02/2012 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 313 shares
@ $4.7785, valued at
$1.5k
|
|
| 07/20/2012 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 263 shares
@ $6.6785, valued at
$1.8k
|
|
| 04/06/2012 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 211 shares
@ $7.0775, valued at
$1.5k
|
|
| 10/27/2011 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 51,760 options to buy
@ $4.07, valued at
$210.7k
Granted 77,640 options to buy
@ $4.07, valued at
$316k
|
|
| 10/27/2011 |
3
| Claiborne Cary J (CFO) has filed a Form 3 on Sucampo Pharmaceuticals, Inc. |
| 02/14/2011 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 12/29/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2009 |
4
| Claiborne Cary J (CEO, CFO and President) has filed a Form 4 on New Generation Biofuels Holdings, Inc|
Txns:
| Bought 1,500 shares
@ $0.71, valued at
$1.1k
Bought 1,019 shares
@ $0.72, valued at
$733.7
Bought 7,481 shares
@ $0.7, valued at
$5.2k
Bought 4,600 shares
@ $0.7, valued at
$3.2k
Bought 5,400 shares
@ $0.69, valued at
$3.7k
|
|
| 12/21/2009 |
4
| Claiborne Cary J (CEO, CFO and President) has filed a Form 4 on New Generation Biofuels Holdings, Inc|
Txns:
| Granted 29,070 shares
@ $0 |
|
| 08/28/2009 |
4
| Claiborne Cary J (CEO, CFO and President) has filed a Form 4 on New Generation Biofuels Holdings, Inc |
| 07/01/2009 |
4/A
| Claiborne Cary J (CEO, CFO and President) has filed a Form 4 on New Generation Biofuels Holdings, Inc |
| 07/01/2009 |
4/A
| Claiborne Cary J (President, CEO & CFO) has filed a Form 4 on New Generation Biofuels Holdings, Inc |
| 06/11/2009 |
4
| Claiborne Cary J (CEO, CFO and President) has filed a Form 4 on New Generation Biofuels Holdings, Inc |
| 05/29/2009 |
4
| Claiborne Cary J (President, CEO & CFO) has filed a Form 4 on New Generation Biofuels Holdings, Inc |
| 01/16/2009 |
4
| Claiborne Cary J (CFO) has filed a Form 4 on New Generation Biofuels Holdings, Inc |